VBI Vaccines (VBIV) Announces Interim Data from Sci-B-Vac Phase IV in HBV; Strong Seroprotection Rates Noted
Go back to VBI Vaccines (VBIV) Announces Interim Data from Sci-B-Vac Phase IV in HBV; Strong Seroprotection Rates Noted| (NASDAQ: VBIV) | Delayed: 0.59 -0.02 (3.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.61 | 52 Week High | $4.35 | |||
| Open | $0.59 | 52 Week Low | $1.76 | |||
| Day High | $0.61 | P/E | N/A | |||
| Day Low | $0.58 | EPS | $0.00 | |||
| Volume | 130,137 | |||||
| Universal Beverages Holdings Corporation (AMEX: VBV) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $0.00 | |||
| Open | $0.00 | 52 Week Low | $0.00 | |||
| Day High | $0.00 | P/E | N/A | |||
| Day Low | $0.00 | EPS | $0.00 | |||
| Volume | 0 | |||||
